Do analysts prefer MEDS or YI?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 111 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, MEDS or YI?

111 has higher revenue and earnings than Wellgistics Health. 111 is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Wellgistics Health $23.34M 0.18 -$101.28M -$46.13 N/A 111 $1.80B 0.02 -$9.65M -$1.40 N/A

Is MEDS or YI more profitable?

111 has a net margin of -0.76% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Wellgistics Health -1,100.16% N/A -171.81% 111 -0.76% N/A -3.80%

Does the media prefer MEDS or YI?

In the previous week, 111 had 1 more articles in the media than Wellgistics Health. MarketBeat recorded 2 mentions for 111 and 1 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 0.00 equaled 111'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wellgistics Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral 111 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend COSM or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cosmos Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media refer more to COSM or MEDS?

In the previous week, Cosmos Health had 14 more articles in the media than Wellgistics Health. MarketBeat recorded 15 mentions for Cosmos Health and 1 mentions for Wellgistics Health. Cosmos Health's average media sentiment score of 0.29 beat Wellgistics Health's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cosmos Health 3 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Wellgistics Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend MEDS or HKPD?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Hong Kong Pharma Digital Technology 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, MEDS or HKPD?

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Wellgistics Health $23.34M 0.18 -$101.28M -$46.13 N/A Hong Kong Pharma Digital Technology $13.43M 0.33 -$1.14M N/A N/A

Is MEDS or HKPD more profitable?

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Wellgistics Health -1,100.16% N/A -171.81% Hong Kong Pharma Digital Technology N/A N/A N/A

Do analysts recommend RDGT or MEDS?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ridgetech 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has stronger earnings and valuation, RDGT or MEDS?

Ridgetech has higher revenue and earnings than Wellgistics Health. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ridgetech $132.16M 0.02 -$1.25M N/A N/A Wellgistics Health $23.34M 0.18 -$101.28M -$46.13 N/A

Is RDGT or MEDS more profitable?

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%. Company Net Margins Return on Equity Return on Assets Ridgetech N/A N/A N/A Wellgistics Health -1,100.16% N/A -171.81%

Do analysts prefer MEDS or MCK?

McKesson has a consensus price target of $973.44, suggesting a potential upside of 7.64%. Given McKesson's stronger consensus rating and higher possible upside, analysts clearly believe McKesson is more favorable than Wellgistics Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Wellgistics Health 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 McKesson 0 Sell rating(s) 4 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.78

Which has better earnings and valuation, MEDS or MCK?

McKesson has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Wellgistics Health $23.34M 0.18 -$101.28M -$46.13 N/A McKesson $403.43B 0.26 $4.76B $37.37 24.20

Does the media prefer MEDS or MCK?

In the previous week, McKesson had 82 more articles in the media than Wellgistics Health. MarketBeat recorded 83 mentions for McKesson and 1 mentions for Wellgistics Health. McKesson's average media sentiment score of 1.56 beat Wellgistics Health's score of 0.00 indicating that McKesson is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Wellgistics Health 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral McKesson 69 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Very Positive

Wellgistics Health (MEDS) Competitors

$1.36 +0.06 (+4.62%)

As of 08/25/2026 04:00 PM Eastern

Compare

MEDS vs. YI, COSM, HKPD, RDGT, and MCK

Should you buy Wellgistics Health stock or one of its competitors? Wellgistics Health's main competitors and comparable companies include 111 (YI), Cosmos Health (COSM), Hong Kong Pharma Digital Technology (HKPD), Ridgetech (RDGT), and McKesson (MCK). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Wellgistics Health compare to 111?

Wellgistics Health (NASDAQ:MEDS) and 111 (NASDAQ:YI) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, profitability, earnings, analyst recommendations, valuation, institutional ownership, media sentiment and risk.

111 has a net margin of -0.76% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-1,100.16%	N/A	-171.81%
111	-0.76%	N/A	-3.80%

5.7% of Wellgistics Health shares are owned by institutional investors. Comparatively, 21.3% of 111 shares are owned by institutional investors. 27.0% of Wellgistics Health shares are owned by company insiders. Comparatively, 43.9% of 111 shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

111 has higher revenue and earnings than Wellgistics Health. 111 is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.18	-$101.28M	-$46.13	N/A
111	$1.80B	0.02	-$9.65M	-$1.40	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
111	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, 111 had 1 more articles in the media than Wellgistics Health. MarketBeat recorded 2 mentions for 111 and 1 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 0.00 equaled 111'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Wellgistics Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
111	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Wellgistics Health has a beta of -1.54, meaning that its share price is 254% less volatile than the broader market. Comparatively, 111 has a beta of 0.67, meaning that its share price is 33% less volatile than the broader market.

Summary

111 beats Wellgistics Health on 9 of the 11 factors compared between the two stocks.

How does Wellgistics Health compare to Cosmos Health?

Cosmos Health (NASDAQ:COSM) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

In the previous week, Cosmos Health had 14 more articles in the media than Wellgistics Health. MarketBeat recorded 15 mentions for Cosmos Health and 1 mentions for Wellgistics Health. Cosmos Health's average media sentiment score of 0.29 beat Wellgistics Health's score of 0.00 indicating that Cosmos Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cosmos Health	3 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Wellgistics Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Cosmos Health has a beta of 4.8, indicating that its share price is 380% more volatile than the broader market. Comparatively, Wellgistics Health has a beta of -1.54, indicating that its share price is 254% less volatile than the broader market.

Cosmos Health has a net margin of -33.08% compared to Wellgistics Health's net margin of -1,100.16%. Wellgistics Health's return on equity of 0.00% beat Cosmos Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cosmos Health	-33.08%	-56.88%	-18.03%
Wellgistics Health	-1,100.16%	N/A	-171.81%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cosmos Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Cosmos Health has higher revenue and earnings than Wellgistics Health. Cosmos Health is trading at a lower price-to-earnings ratio than Wellgistics Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cosmos Health	$65.27M	0.19	-$19.15M	-$0.64	N/A
Wellgistics Health	$23.34M	0.18	-$101.28M	-$46.13	N/A

12.6% of Cosmos Health shares are held by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are held by institutional investors. 26.2% of Cosmos Health shares are held by insiders. Comparatively, 27.0% of Wellgistics Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Cosmos Health beats Wellgistics Health on 10 of the 13 factors compared between the two stocks.

How does Wellgistics Health compare to Hong Kong Pharma Digital Technology?

Wellgistics Health (NASDAQ:MEDS) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, risk, dividends, analyst recommendations, earnings and valuation.

5.7% of Wellgistics Health shares are held by institutional investors. 27.0% of Wellgistics Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Hong Kong Pharma Digital Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Wellgistics Health and Wellgistics Health both had 1 articles in the media. Wellgistics Health's average media sentiment score of 0.00 equaled Hong Kong Pharma Digital Technology'saverage media sentiment score.

Company	Overall Sentiment
Wellgistics Health	Neutral
Hong Kong Pharma Digital Technology	Neutral

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.18	-$101.28M	-$46.13	N/A
Hong Kong Pharma Digital Technology	$13.43M	0.33	-$1.14M	N/A	N/A

Wellgistics Health has a beta of -1.54, indicating that its share price is 254% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.33, indicating that its share price is 133% more volatile than the broader market.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-1,100.16%	N/A	-171.81%
Hong Kong Pharma Digital Technology	N/A	N/A	N/A

Summary

Hong Kong Pharma Digital Technology beats Wellgistics Health on 5 of the 8 factors compared between the two stocks.

How does Wellgistics Health compare to Ridgetech?

Ridgetech (NASDAQ:RDGT) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, profitability, media sentiment, valuation, risk and earnings.

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -1,100.16%.

Company	Net Margins	Return on Equity	Return on Assets
Ridgetech	N/A	N/A	N/A
Wellgistics Health	-1,100.16%	N/A	-171.81%

45.3% of Ridgetech shares are held by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are held by institutional investors. 22.6% of Ridgetech shares are held by company insiders. Comparatively, 27.0% of Wellgistics Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Ridgetech has a beta of -0.13, meaning that its stock price is 113% less volatile than the broader market. Comparatively, Wellgistics Health has a beta of -1.54, meaning that its stock price is 254% less volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ridgetech	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Ridgetech has higher revenue and earnings than Wellgistics Health.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ridgetech	$132.16M	0.02	-$1.25M	N/A	N/A
Wellgistics Health	$23.34M	0.18	-$101.28M	-$46.13	N/A

In the previous week, Ridgetech had 1 more articles in the media than Wellgistics Health. MarketBeat recorded 2 mentions for Ridgetech and 1 mentions for Wellgistics Health. Ridgetech's average media sentiment score of 0.00 equaled Wellgistics Health'saverage media sentiment score.

Company	Overall Sentiment
Ridgetech	Neutral
Wellgistics Health	Neutral

Summary

Ridgetech beats Wellgistics Health on 7 of the 9 factors compared between the two stocks.

How does Wellgistics Health compare to McKesson?

Wellgistics Health (NASDAQ:MEDS) and McKesson (NYSE:MCK) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.

5.7% of Wellgistics Health shares are owned by institutional investors. Comparatively, 85.1% of McKesson shares are owned by institutional investors. 27.0% of Wellgistics Health shares are owned by insiders. Comparatively, 0.1% of McKesson shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

McKesson has a net margin of 1.12% compared to Wellgistics Health's net margin of -1,100.16%. Wellgistics Health's return on equity of 0.00% beat McKesson's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Wellgistics Health	-1,100.16%	N/A	-171.81%
McKesson	1.12%	-253.21%	5.90%

McKesson has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Wellgistics Health	$23.34M	0.18	-$101.28M	-$46.13	N/A
McKesson	$403.43B	0.26	$4.76B	$37.37	24.20

McKesson has a consensus price target of $973.44, suggesting a potential upside of 7.64%. Given McKesson's stronger consensus rating and higher possible upside, analysts clearly believe McKesson is more favorable than Wellgistics Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Wellgistics Health	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
McKesson	0 Sell rating(s)	4 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.78

Wellgistics Health has a beta of -1.54, indicating that its share price is 254% less volatile than the broader market. Comparatively, McKesson has a beta of 0.3, indicating that its share price is 70% less volatile than the broader market.

In the previous week, McKesson had 82 more articles in the media than Wellgistics Health. MarketBeat recorded 83 mentions for McKesson and 1 mentions for Wellgistics Health. McKesson's average media sentiment score of 1.56 beat Wellgistics Health's score of 0.00 indicating that McKesson is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Wellgistics Health	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
McKesson	69 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

McKesson beats Wellgistics Health on 14 of the 16 factors compared between the two stocks.

Get Wellgistics Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MEDS vs. The Competition

Export

Metric	Wellgistics Health	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.99M	$9.98B	$7.35B	$12.72B
Dividend Yield	N/A	2.55%	2.53%	11.02%
P/E Ratio	-0.03	34.99	270.96	24.14
Price / Sales	0.18	5.07	634.76	101.59
Price / Cash	N/A	125.58	78.57	53.12
Price / Book	-0.21	4.08	13.14	6.25
Net Income	-$101.28M	$312.92M	$3.46B	$347.86M
7 Day Performance	-60.69%	-0.06%	1.52%	0.98%
1 Month Performance	-60.69%	1.39%	8.82%	5.24%
1 Year Performance	-98.43%	16.20%	26.08%	17.04%

Wellgistics Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MEDS Wellgistics Health	0.343 of 5 stars	$1.36 +4.6%	N/A	-98.3%	$3.99M	$23.34M	N/A	31	Gap Down
YI 111	0.8132 of 5 stars	$3.57 flat	N/A	-48.5%	$31.36M	$11.39B	N/A	1,063	News Coverage Gap Up
COSM Cosmos Health	2.0273 of 5 stars	$0.22 flat	N/A	-74.9%	$13.30M	$73.73M	N/A	100	News Coverage Earnings Report Gap Up
HKPD Hong Kong Pharma Digital Technology	0.5615 of 5 stars	$0.41 flat	N/A	-62.1%	$4.50M	$13.43M	N/A	19	Gap Down
RDGT Ridgetech	0.5418 of 5 stars	$0.81 flat	N/A	-99.6%	$2.94M	$132.16M	N/A	980	Short Interest Increase

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MEDS) was last updated on 8/26/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Wellgistics Health (MEDS) Competitors

MEDS vs. YI, COSM, HKPD, RDGT, and MCK

How does Wellgistics Health compare to 111?

Summary

How does Wellgistics Health compare to Cosmos Health?

Summary

How does Wellgistics Health compare to Hong Kong Pharma Digital Technology?

Summary

How does Wellgistics Health compare to Ridgetech?

Summary

How does Wellgistics Health compare to McKesson?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEDS vs. The Competition

Wellgistics Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Wellgistics Health (MEDS) Competitors

MEDS vs. YI, COSM, HKPD, RDGT, and MCK

How does Wellgistics Health compare to 111?

Is MEDS or YI more profitable?

Do insiders & institutionals hold more shares of MEDS or YI?

Which has stronger earnings and valuation, MEDS or YI?

Do analysts prefer MEDS or YI?

Does the media prefer MEDS or YI?

Which has more volatility & risk, MEDS or YI?

Summary

How does Wellgistics Health compare to Cosmos Health?

Does the media refer more to COSM or MEDS?

Which has more volatility & risk, COSM or MEDS?

Is COSM or MEDS more profitable?

Do analysts recommend COSM or MEDS?

Which has stronger valuation and earnings, COSM or MEDS?

Do insiders and institutionals believe in COSM or MEDS?

Summary

How does Wellgistics Health compare to Hong Kong Pharma Digital Technology?

Do insiders & institutionals believe in MEDS or HKPD?

Do analysts recommend MEDS or HKPD?

Does the media prefer MEDS or HKPD?

Which has better earnings & valuation, MEDS or HKPD?

Which has more volatility and risk, MEDS or HKPD?

Is MEDS or HKPD more profitable?

Summary

How does Wellgistics Health compare to Ridgetech?

Is RDGT or MEDS more profitable?

Do institutionals and insiders have more ownership in RDGT or MEDS?

Which has more risk & volatility, RDGT or MEDS?

Do analysts recommend RDGT or MEDS?

Which has stronger earnings and valuation, RDGT or MEDS?

Does the media favor RDGT or MEDS?

Summary

How does Wellgistics Health compare to McKesson?

Do institutionals and insiders hold more shares of MEDS or MCK?

Is MEDS or MCK more profitable?

Which has better earnings and valuation, MEDS or MCK?

Do analysts prefer MEDS or MCK?

Which has more volatility and risk, MEDS or MCK?

Does the media prefer MEDS or MCK?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MEDS vs. The Competition

Wellgistics Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools